Huber Pharma

Huber pharmaceutical started its operation as peptide manufacture way back in 2014 at Avicenna National Biotechnological Park in Tehran-Iran. The commercial production of its first product was started in October 2016. In 2017, the company had further enhanced its operations by inducing new production facilitation for solid phase manufacture of peptides. Today we have carved a niche for ourselves in the exceedingly competitive and quality conscious field & peptide manufacturing. We aim to be amongst global leaders in peptide manufactures. Huber pharma’s facilities have received local regulatory approvals for its facilities as well as for the product from food and drug organization and regarding good conditions of its facilities it will receive international regulatory approvals without major problems. At Huber pharma, we make every efforts to create an environment of transparency and openness Our ultimate goal is to manufacture qualified products in good condition to help all levels of society in living healthier lives.